vs

Side-by-side financial comparison of HARROW, INC. (HROW) and MP Materials Corp. (MP). Click either name above to swap in a different company.

MP Materials Corp. is the larger business by last-quarter revenue ($90.6M vs $89.1M, roughly 1.0× HARROW, INC.). HARROW, INC. runs the higher net margin — 7.4% vs -8.8%, a 16.2% gap on every dollar of revenue. On growth, MP Materials Corp. posted the faster year-over-year revenue change (49.1% vs 33.3%). Over the past eight quarters, MP Materials Corp.'s revenue compounded faster (70.3% CAGR vs 60.5%).

Harrow Health, Inc., formerly known as Imprimis Pharmaceuticals, is a publicly traded pharmaceutical company based in Nashville, Tennessee.

MP Materials Corp. is a U.S.-based producer of rare earth materials. The company owns and operates the Mountain Pass mine in California, the only active rare earth mining and processing facility in the Western Hemisphere, producing essential materials for electric vehicles, wind turbines, and defense applications.

HROW vs MP — Head-to-Head

Bigger by revenue
MP
MP
1.0× larger
MP
$90.6M
$89.1M
HROW
Growing faster (revenue YoY)
MP
MP
+15.8% gap
MP
49.1%
33.3%
HROW
Higher net margin
HROW
HROW
16.2% more per $
HROW
7.4%
-8.8%
MP
Faster 2-yr revenue CAGR
MP
MP
Annualised
MP
70.3%
60.5%
HROW

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
HROW
HROW
MP
MP
Revenue
$89.1M
$90.6M
Net Profit
$6.6M
$-8.0M
Gross Margin
79.3%
Operating Margin
17.5%
Net Margin
7.4%
-8.8%
Revenue YoY
33.3%
49.1%
Net Profit YoY
-2.2%
64.8%
EPS (diluted)
$0.20
$-0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HROW
HROW
MP
MP
Q1 26
$90.6M
Q4 25
$89.1M
$52.7M
Q3 25
$71.6M
$53.6M
Q2 25
$63.7M
$57.4M
Q1 25
$47.8M
$60.8M
Q4 24
$66.8M
$61.0M
Q3 24
$49.3M
$62.9M
Q2 24
$48.9M
$31.3M
Net Profit
HROW
HROW
MP
MP
Q1 26
$-8.0M
Q4 25
$6.6M
$9.4M
Q3 25
$1.0M
$-41.8M
Q2 25
$5.0M
$-30.9M
Q1 25
$-17.8M
$-22.6M
Q4 24
$6.8M
$-22.3M
Q3 24
$-4.2M
$-25.5M
Q2 24
$-6.5M
$-34.1M
Gross Margin
HROW
HROW
MP
MP
Q1 26
Q4 25
79.3%
Q3 25
75.3%
Q2 25
74.5%
Q1 25
67.5%
Q4 24
78.8%
Q3 24
75.6%
Q2 24
74.4%
Operating Margin
HROW
HROW
MP
MP
Q1 26
Q4 25
17.5%
-7.0%
Q3 25
20.6%
-125.2%
Q2 25
17.9%
-76.5%
Q1 25
-23.5%
-57.2%
Q4 24
19.3%
-72.1%
Q3 24
2.7%
-62.8%
Q2 24
3.1%
-171.1%
Net Margin
HROW
HROW
MP
MP
Q1 26
-8.8%
Q4 25
7.4%
17.9%
Q3 25
1.4%
-78.0%
Q2 25
7.8%
-53.8%
Q1 25
-37.2%
-37.2%
Q4 24
10.1%
-36.6%
Q3 24
-8.6%
-40.5%
Q2 24
-13.2%
-108.9%
EPS (diluted)
HROW
HROW
MP
MP
Q1 26
$-0.04
Q4 25
$0.20
$0.07
Q3 25
$0.03
$-0.24
Q2 25
$0.13
$-0.19
Q1 25
$-0.50
$-0.14
Q4 24
$0.19
$-0.12
Q3 24
$-0.12
$-0.16
Q2 24
$-0.18
$-0.21

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HROW
HROW
MP
MP
Cash + ST InvestmentsLiquidity on hand
$72.9M
$1.7B
Total DebtLower is stronger
$250.0M
$1.0B
Stockholders' EquityBook value
$52.4M
$2.0B
Total Assets
$399.5M
$3.8B
Debt / EquityLower = less leverage
4.77×
0.51×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HROW
HROW
MP
MP
Q1 26
$1.7B
Q4 25
$72.9M
$1.2B
Q3 25
$74.3M
$1.1B
Q2 25
$53.0M
$261.5M
Q1 25
$66.7M
$198.3M
Q4 24
$47.2M
$282.4M
Q3 24
$72.6M
$284.4M
Q2 24
$71.0M
$295.6M
Total Debt
HROW
HROW
MP
MP
Q1 26
$1.0B
Q4 25
$250.0M
$998.7M
Q3 25
$347.2M
$997.3M
Q2 25
$250.6M
$910.8M
Q1 25
$256.9M
$909.8M
Q4 24
$262.7M
$908.7M
Q3 24
$230.7M
Q2 24
$236.3M
Stockholders' Equity
HROW
HROW
MP
MP
Q1 26
$2.0B
Q4 25
$52.4M
$2.0B
Q3 25
$47.0M
$2.0B
Q2 25
$49.7M
$1.0B
Q1 25
$56.5M
$1.0B
Q4 24
$69.7M
$1.1B
Q3 24
$58.0M
$1.1B
Q2 24
$58.5M
$1.1B
Total Assets
HROW
HROW
MP
MP
Q1 26
$3.8B
Q4 25
$399.5M
$3.9B
Q3 25
$363.1M
$3.8B
Q2 25
$345.0M
$2.3B
Q1 25
$364.2M
$2.4B
Q4 24
$389.0M
$2.3B
Q3 24
$351.5M
$2.3B
Q2 24
$306.6M
$2.4B
Debt / Equity
HROW
HROW
MP
MP
Q1 26
0.51×
Q4 25
4.77×
0.50×
Q3 25
7.39×
0.51×
Q2 25
5.05×
0.90×
Q1 25
4.55×
0.88×
Q4 24
3.77×
0.86×
Q3 24
3.98×
Q2 24
4.04×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HROW
HROW
MP
MP
Operating Cash FlowLast quarter
$8.4M
$-1.9M
Free Cash FlowOCF − Capex
$8.1M
FCF MarginFCF / Revenue
9.1%
Capex IntensityCapex / Revenue
0.4%
Cash ConversionOCF / Net Profit
1.27×
TTM Free Cash FlowTrailing 4 quarters
$43.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HROW
HROW
MP
MP
Q1 26
$-1.9M
Q4 25
$8.4M
$-46.9M
Q3 25
$16.6M
$-42.0M
Q2 25
$-803.0K
$-3.7M
Q1 25
$19.7M
$-63.2M
Q4 24
$-17.8M
$30.5M
Q3 24
$3.0M
$-6.8M
Q2 24
$-2.7M
$30.8M
Free Cash Flow
HROW
HROW
MP
MP
Q1 26
Q4 25
$8.1M
$-109.3M
Q3 25
$16.4M
$-92.5M
Q2 25
$-969.0K
$-32.7M
Q1 25
$19.5M
$-93.7M
Q4 24
$-18.3M
$-11.2M
Q3 24
$2.3M
$-53.3M
Q2 24
$-3.1M
$-15.6M
FCF Margin
HROW
HROW
MP
MP
Q1 26
Q4 25
9.1%
-207.4%
Q3 25
22.9%
-172.8%
Q2 25
-1.5%
-56.9%
Q1 25
40.8%
-154.0%
Q4 24
-27.4%
-18.3%
Q3 24
4.8%
-84.7%
Q2 24
-6.3%
-50.1%
Capex Intensity
HROW
HROW
MP
MP
Q1 26
Q4 25
0.4%
118.5%
Q3 25
0.3%
94.3%
Q2 25
0.3%
50.5%
Q1 25
0.4%
50.1%
Q4 24
0.8%
68.3%
Q3 24
1.2%
73.8%
Q2 24
0.7%
148.7%
Cash Conversion
HROW
HROW
MP
MP
Q1 26
Q4 25
1.27×
-4.97×
Q3 25
16.26×
Q2 25
-0.16×
Q1 25
Q4 24
-2.62×
Q3 24
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HROW
HROW

Segment breakdown not available.

MP
MP

Materials Segment$72.2M80%
Magnetics Segment$21.1M23%

Related Comparisons